Sanara Medtech Inc (NASDAQ: SMTI) stock enjoyed a major increase of 10.9% on 1/22/25. The shares closed at $37.72. Moreover, trading volume in this advance was exceptionally high at 327% of normal. The stock has risen 16.2% during the last week and has been strong relative to the market over the last nine months.
Current PriceTarget Research Rating
Sanara Medtech has a current Value Trend Rating of D (Negative). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing very contradictory signals. Sanara Medtech has a very low Appreciation Score of 8 but a slightly positive Power Rating of 64, with the Negative Value Trend Rating the result.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment